Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
M Baccarani, G Saglio, J Goldman, A Hochhaus… - Blood, 2006 - ashpublications.org
The introduction of imatinib mesylate (IM) has revolutionized the treatment of chronic
myeloid leukemia (CML). Although experience is too limited to permit evidence-based …
myeloid leukemia (CML). Although experience is too limited to permit evidence-based …
Chronic myeloid leukemia—advances in biology and new approaches to treatment
JM Goldman, JV Melo - New England Journal of Medicine, 2003 - Mass Medical Soc
An extraordinary series of discoveries about chronic myeloid leukemia (CML) has made this
disease a model of the way in which bench and bedside research can unite and culminate …
disease a model of the way in which bench and bedside research can unite and culminate …
Chronic myeloid leukemia: diagnosis and treatment
A Quintás-Cardama, JE Cortes - Mayo Clinic Proceedings, 2006 - Elsevier
Chronic myeloid leukemia (CML) has become a model in research and management among
malignant disorders. Since the discovery of the presence of a unique and constant …
malignant disorders. Since the discovery of the presence of a unique and constant …
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper
S Soverini, E Abruzzese, M Bocchia… - Journal of hematology & …, 2019 - Springer
Abstract BCR-ABL1 kinase domain (KD) mutation status is considered to be an important
element of clinical decision algorithms for chronic myeloid leukemia (CML) patients who do …
element of clinical decision algorithms for chronic myeloid leukemia (CML) patients who do …
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations
S Sembill, M Ampatzidou, S Chaudhury, M Dworzak… - Leukemia, 2023 - nature.com
Abstract Treatment of chronic myeloid leukemia has improved significantly with the
introduction of tyrosine kinase inhibitors (TKIs), and treatment guidelines based on …
introduction of tyrosine kinase inhibitors (TKIs), and treatment guidelines based on …
Hematopoietic cell transplantation, version 2.2020, NCCN clinical practice guidelines in oncology
Hematopoietic cell transplantation (HCT) involves the infusion of hematopoietic progenitor
cells into patients with hematologic disorders with the goal of re-establishing normal …
cells into patients with hematologic disorders with the goal of re-establishing normal …
Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study
The purpose of this study was to analyze medical late effects among patients with chronic
myeloid leukemia (CML) treated with hematopoietic cell transplantation (HCT). Subjects …
myeloid leukemia (CML) treated with hematopoietic cell transplantation (HCT). Subjects …
BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia
MHC class I chain-related molecules (MIC) participate in immune surveillance of cancer
through engagement of the NKG2D-activating receptor on NK and T cells. Decreased …
through engagement of the NKG2D-activating receptor on NK and T cells. Decreased …
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia
VG Oehler, T Gooley, DS Snyder, L Johnston, A Lin… - Blood, 2007 - ashpublications.org
The impact of imatinib mesylate (IM) treatment for chronic myeloid leukemia (CML) on
subsequent allogeneic transplantation is uncertain. To better understand this relationship …
subsequent allogeneic transplantation is uncertain. To better understand this relationship …
Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define …
We identified 243 patients with Philadelphia (Ph) chromosome–positive chronic myeloid
leukemia (CML) who had BCR-ABL transcripts monitored by quantitative reverse …
leukemia (CML) who had BCR-ABL transcripts monitored by quantitative reverse …